Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs GPC✓SelectedUSD · GPCGSK vs GPC performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs GPC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.1%
GPC return
+68.2%
Excess return
+28.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGPCExcessAlpha
1D-0.1%-2.5%+2.4%+0.5%
7D-5.3%-3.9%-1.4%-4.4%
30D-3.7%-5.0%+1.4%-2.5%
3M-7.3%-10.1%+2.9%-5.0%
6M-4.2%+27.1%-31.4%-9.9%
YTD+0.9%-0.9%+1.8%-0.2%
1Y+7.3%-1.8%+9.1%+6.3%
3Y+52.7%-5.1%+57.8%+49.7%
5Y+40.1%+1.3%+38.9%+32.3%
All+97.1%+68.2%+28.9%+54.4%

Cumulative growth

Daily Returns

Daily percentage return beside GPC.

Daily Out/Under-Performance

Portfolio return minus GPC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GPC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GPC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling